NFκB pathway: A good signaling paradigm and therapeutic target
- 1 January 2006
- journal article
- review article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 38 (10) , 1647-1653
- https://doi.org/10.1016/j.biocel.2006.03.023
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivoGenes & Development, 2005
- Distinct roles of IκB proteins in regulating constitutive NF-κB activityNature Cell Biology, 2005
- Regulation of NF-κB by atypical activators and tumour suppressorsBiochemical Society Transactions, 2004
- De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signallingNature, 2004
- Degradation of Promoter-bound p65/RelA Is Essential for the Prompt Termination of the Nuclear Factor κB ResponseThe Journal of Experimental Medicine, 2004
- IκB Kinase-Independent IκBα Degradation Pathway: Functional NF-κB Activity and Implications for Cancer TherapyMolecular and Cellular Biology, 2003
- Sequential Modification of NEMO/IKKγ by SUMO-1 and Ubiquitin Mediates NF-κB Activation by Genotoxic StressCell, 2003
- NF-κB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanismGenes & Development, 2003
- Modulation of NF-κB Activity by Exchange of DimersMolecular Cell, 2003
- Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit PhosphorylationScience, 1999